A GIP/xenin hybrid in combination with exendin-4 improves metabolic status in db/db diabetic mice and promotes enduring antidiabetic benefits in high fat fed mice.
Biochem Pharmacol
; 171: 113723, 2020 01.
Article
in En
| MEDLINE
| ID: mdl-31756326
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Neurotensin
/
Gastric Inhibitory Polypeptide
/
Diabetes Mellitus, Experimental
/
Diabetes Mellitus, Type 2
/
Energy Metabolism
/
Exenatide
Type of study:
Etiology_studies
Limits:
Animals
Language:
En
Journal:
Biochem Pharmacol
Year:
2020
Document type:
Article
Country of publication:
United kingdom